Search the Newsreel

How Earnings Turnaround And FX-Hit Outlook At Integra LifeSciences (IART) Has Changed Its Investment Story

Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART

Quantinno Capital Management LP significantly reduced its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 45.4% in the first quarter of 2026, selling 382,663 shares. Despite this reduction, other institutional investors like Paradigm Capital, Sei Investments, and Walleye Capital increased their holdings, maintaining high …

Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart

5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call

Integra LifeSciences reported Q2 results with flat revenue due to reimbursement pressures and challenging year-over-year comparisons, though adjusted EPS outperformed expectations. Analysts focused on the company's full-year guidance, CEO's return, demand for Integra Skin, and the relaunch of SurgiMend. Upcoming quarters will see monitoring …

Is Integra LifeSciences Holdings (IART) Undervalued As Profit Returns And Guidance Resets?

Integra LifeSciences Holdings (IART) Returns To Profit As Fair Value Debate Stays In Focus

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Integra LifeSciences Holdings earnings and guidance draw investor focus Integra LifeSciences Holdings (IART) has come back into focus after reporting second quarter 2026 results with …

Why Integra LifeSciences (IART) Trimmed Its 2026 Outlook After Returning to Profitability

Integra LifeSciences Holdings reported past second-quarter 2026 results with sales of US$418.76 million and net income of US$4.48 million, and issued third-quarter revenue guidance of US$410 million to US$425 million while slightly trimming its full-year 2026 outlook to US$1.65 billion to US$1.70 billion due …

integra lifesciences holdings corp Profit Warnings

This page provides information on Integra Lifesciences Holdings Corp's profit warnings and related financial news. It lists a specific profit warning for FY26 with a revised revenue range. The page also features a compilation of recent news articles concerning Integra LifeSciences, detailing earnings, leadership …

IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook

IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 million. The company expects next quarter's revenue to …

Integra LifeSciences (IART) 10K Form and Latest SEC Filings 2026

This article details Integra LifeSciences' (IART) SEC filings history, emphasizing that these documents are crucial for investors as a primary source of verified financial data. It highlights the company has submitted over 437 documents since 2017, with the most recent being a Form SCHEDULE …

Vanguard Portfolio Management (IART) discloses 3.9M-share position in Integra

Vanguard Portfolio Management has disclosed a beneficial ownership of 3,912,816 shares, representing 5.02% of Integra LifeSciences Holdings Corp (IART) common stock, as of June 30, 2026. This Schedule 13G filing indicates Vanguard has sole voting power over 169,723 shares and sole dispositive power over …

Integra LifeSciences (IART) Stock Rebounds As Margin Repair Gains Credibility

Integra LifeSciences Holdings Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IART) 2026-07-31

Integra LifeSciences Holdings Corporation Q2 2026 Earnings Call Summary - Moby Operational Stabilization and Strategic Execution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences

Zacks.com has identified Bassett Furniture Industries (BSET), Aveanna Healthcare Holdings (AVAH), and Integra LifeSciences Holdings (IART) as stocks with breakout potential ahead of August. The article emphasizes identifying stocks within defined trading ranges and highlights the importance of support and resistance levels to spot …

Integra Lifesciences Holdings Corp (IART) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Integra Lifesciences Holdings Corp (IART), highlighting its current valuation score of 8.05, which ranks 83rd in the Healthcare Equipment & Supplies industry. It details the company's current P/E ratio at -2.58, noting significant deviations from recent highs …

3 Stocks Showing Breakout Potential Ahead of August

As August approaches, a relatively weak month for the stock market, investors should take a more active approach to stock selection, identifying potential breakout opportunities within defined trading ranges. Going by this approach, a stock should be sold if it falls below the lower …

Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Integra LifeSciences (IART) reported revenue of $418.76 million, up 0.8% over the same period last year. EPS came in at $0.56, compared to $0.45 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Integra LifeSciences (IART) Q2 Earnings Top Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Integra Lifesciences Q3 Results: Sales guidance beats estimates

Integra Lifesciences projects Q3 adjusted EPS between $0.53-$0.61 and sales of $410-$425 million, with the sales guidance exceeding analyst estimates. While profit expectations align with consensus, the higher sales forecast indicates potential revenue upside. This guidance highlights the company's confidence in maintaining demand and …

Integra Lifesciences Latest Results: Sales guidance lowered to $1.654B-$1.695B

Integra Lifesciences has lowered its sales guidance for FY2026 to a range of $1.654 billion to $1.695 billion, which is below the analyst consensus estimate of $1.676 billion. Despite this downward revision in revenue, the company affirmed its adjusted earnings per share (EPS) guidance …

Integra: Q2 Earnings Snapshot

This article provides a second-quarter earnings snapshot for Integra.

Integra LifeSciences Reports Second Quarter 2026 Results, Updates Full-Year Revenue Guidance and Reaffirms EPS Outlook

Integra LifeSciences announced its Q2 2026 financial results, reporting revenues of $418.8 million and a significant improvement in GAAP net income from a loss to $4.5 million. The company updated its full-year revenue guidance due to foreign exchange impacts but reaffirmed its organic growth …

Integra starts production for planned fourth-quarter SurgiMend relaunch

Integra LifeSciences (Nasdaq: IART) reported Q2 2026 revenue of $418.8 million, a 0.8% increase year-over-year, with GAAP EPS at $0.06 and adjusted EPS at $0.56. The company reaffirmed its full-year 2026 organic revenue growth and adjusted EPS guidance, while slightly lowering reported revenue guidance …

Why Integra LifeSciences (IART) Shares Are Sliding Today

Why Integra LifeSciences (IART) Shares Are Sliding Today What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-quarter earnings beat was overshadowed by concerns about flat revenue growth and declining profitability. While …

Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Integra LifeSciences's (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street's revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 million. The company expects next quarter's revenue to be …

Integra LifeSciences (IART) Earnings Date and Reports 2026 $IART

Integra LifeSciences (NASDAQ: IART) swings from 2025 loss to Q2 2026 profit

Integra LifeSciences earnings up next: Can turnaround hold?

Integra LifeSciences is set to report second-quarter earnings, with investors looking for sustained operational recovery following manufacturing issues. Analysts project $0.48 EPS and $417.6 million in revenue, but maintain a neutral rating due to past guidance cuts and questions about consistent results. The company's …

PT Bank Multiarta Sentosa Tbk Revenue Breakdown – IDX:MASB

Integra Lifesciences Holdings Corp

This article provides a detailed revenue breakdown for Integra Lifesciences Holdings Corp (IART) by business segments and geographical regions. It shows Neurosurgery as the largest revenue contributor among business segments, and the United States as the dominant region for its revenue. The financial data …

Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Integra Lifesciences Holdings Corp's (IART) dividend history and stock splits. It states that the company has distributed a total of $0.00 in dividends over the past five years, indicating no recent dividend payouts. Key information like market cap, …

IART|Integra Lifesciences Holdings Corp|Price:19.530|Chg%:-0.260

This article provides a comprehensive stock analysis of Integra Lifesciences Holdings Corp (IART) based on TradingKey's stock score system. It highlights the company's stable fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. The analysis also notes high institutional …

Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect

Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here's what to look for. Integra LifeSciences beat analysts' revenue expectations last quarter, reporting revenues of $391.9 million, …